메뉴 건너뛰기
Lancet Oncology
Volumn 7, Issue 9, 2006, Pages 703-704
Don't forget survival, please...
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT; NEW DRUG;
EID: 33747869887     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(06)70839-7     Document Type: Letter
Times cited : (4)
References (8)
  • 1
    • 24644440601 scopus 로고    scopus 로고
    • Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients
    • Bruzzi P., Del Mastro L., Sormani M., et al. Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients. J Clin Oncol 23 (2005) 5117-5125
    • (2005) J Clin Oncol , vol.23 , pp. 5117-5125
    • Bruzzi, P.1    Del Mastro, L.2    Sormani, M.3
  • 2
    • 0034729931 scopus 로고    scopus 로고
    • Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer
    • Buyse M., Thirion P., Carlson R., et al. Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer. Lancet 356 (2000) 373-378
    • (2000) Lancet , vol.356 , pp. 373-378
    • Buyse, M.1    Thirion, P.2    Carlson, R.3
  • 3
    • 33644834827 scopus 로고    scopus 로고
    • Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials
    • Sargent D., Wieand H., Haller D., et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 23 (2005) 8664-8670
    • (2005) J Clin Oncol , vol.23 , pp. 8664-8670
    • Sargent, D.1    Wieand, H.2    Haller, D.3
  • 4
    • 0035154256 scopus 로고    scopus 로고
    • Clinical trial designs for cytostatic agents: are new approaches needed?
    • Korn E., Arbuck S., Pluda J., et al. Clinical trial designs for cytostatic agents: are new approaches needed?. J Clin Oncol 19 (2001) 265-272
    • (2001) J Clin Oncol , vol.19 , pp. 265-272
    • Korn, E.1    Arbuck, S.2    Pluda, J.3
  • 5
    • 33747844588 scopus 로고    scopus 로고
    • Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis
    • Johnson K., Ringland C., Stokes B., et al. Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis. Lancet Oncol 7 (2006) 741-746
    • (2006) Lancet Oncol , vol.7 , pp. 741-746
    • Johnson, K.1    Ringland, C.2    Stokes, B.3
  • 6
    • 0035868913 scopus 로고    scopus 로고
    • Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results
    • Breathnach O., Freidlin B., Conley B., et al. Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. J Clin Oncol 19 (2001) 1734-1742
    • (2001) J Clin Oncol , vol.19 , pp. 1734-1742
    • Breathnach, O.1    Freidlin, B.2    Conley, B.3
  • 7
    • 6944247669 scopus 로고    scopus 로고
    • Accelerated approval of oncology products: a decade of experience
    • Dagher R., Johnson J., Williams G., et al. Accelerated approval of oncology products: a decade of experience. J Natl Cancer Inst 96 (2004) 1500-1509
    • (2004) J Natl Cancer Inst , vol.96 , pp. 1500-1509
    • Dagher, R.1    Johnson, J.2    Williams, G.3
  • 8
    • 26944477841 scopus 로고    scopus 로고
    • Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures
    • Apolone G., Joppi R., Bertele' V., and Garattini S. Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures. Br J Cancer 93 (2005) 504-509
    • (2005) Br J Cancer , vol.93 , pp. 504-509
    • Apolone, G.1    Joppi, R.2    Bertele', V.3    Garattini, S.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.